Sky Ventures Group

Investment decisions are made by the principals: Chuck Goldman, David Abraham, and Raza Shaikh. Goldman, a former Apple executive who founded Apperian, serves as Executive Director. Abraham is CEO of Phoenix Pharmaceutical Group. Shaikh founded Beacon Venture Partners. The three operate without a disclosed formal investment committee structure, consistent with a partnership model where each principal brings deal flow from their respective operating and network activities.

Deal sourcing runs through the principals' operating networks and professional memberships. Several principals are active members of Launchpad Venture Group, a Boston-based angel network that provides early-stage deal flow. The firm also participates in MassChallenge, where principals serve as speakers and advisors, and attends Biotechnology Innovation Organization conferences, which connect the group to life sciences opportunities. Each principal additionally sources through their own companies — Goldman from enterprise software, Abraham from pharmaceuticals, and Shaikh from his venture partner network.

Sky Ventures operates more like an organized angel network than a traditional venture capital firm. The principals co-invest personal capital rather than managing committed third-party funds. There are no publicly identified limited partners, fund vehicles, or institutional fundraising cycles. Each named principal simultaneously runs an operating company — Apperian alumni Goldman, Phoenix Pharmaceutical CEO Abraham, and Beacon Venture Partners founder Shaikh invest through Sky Ventures as their shared platform.

The firm targets early-stage companies, including seed, start-up, and growth rounds. The generalist venture mandate covers multiple check sizes across stages, consistent with a principal-driven model where investment amounts flex based on opportunity and individual principal participation rather than a fixed fund strategy.

Confirmed sector focuses include enterprise software, digital health, and consumer technology. The enterprise software focus connects to Chuck Goldman's background leading Apple's enterprise consulting arm and founding Apperian. Digital health and life sciences align with David Abraham's pharmaceutical operating experience and the group's participation in BIO conferences. Gaming represents the consumer technology exposure through the GamerBoom investment.